Free Trial
NASDAQ:CV

CapsoVision (CV) Stock Price, News & Analysis

CapsoVision logo
$4.10 +0.19 (+4.86%)
As of 08/4/2025 04:00 PM Eastern

About CapsoVision Stock (NASDAQ:CV)

Key Stats

Today's Range
$3.86
$4.11
50-Day Range
N/A
52-Week Range
$3.49
$5.72
Volume
74,900 shs
Average Volume
127,238 shs
Market Capitalization
$189.99 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.50
Consensus Rating
Strong Buy

Company Overview

Receive CV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CapsoVision and its competitors with MarketBeat's FREE daily newsletter.

CV Stock News Headlines

Roth Capital Predicts CapsoVision's Q2 Earnings (NASDAQ:CV)
Turn $1K into $50K with This DeFi Gem
I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. This is about being in the right place at the right time – and I believe that time is now.
CapsoVision (NASDAQ:CV) Coverage Initiated at Benchmark
Roth Capital Upgrades CapsoVision (NASDAQ:CV) to Strong-Buy
See More Headlines

CV Stock Analysis - Frequently Asked Questions

CapsoVision's stock was trading at $4.57 on January 1st, 2025. Since then, CV shares have decreased by 10.3% and is now trading at $4.10.

CapsoVision (CV) raised $28 million in an initial public offering on Wednesday, July 2nd 2025. The company issued 5,300,000 shares at $5.00-$5.50 per share. The Benchmark Company and Roth Capital Partners acted as the underwriters for the IPO.

CapsoVision's quiet period expires on Monday, August 11th. CapsoVision had issued 5,500,000 shares in its initial public offering on July 2nd. The total size of the offering was $27,500,000 based on an initial share price of $5.00. During CapsoVision's quiet period, insiders and any underwriters involved in the IPO are restricted from issuing any research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the expiration of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

Shares of CV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Surgical, Medical, And Dental Instruments And Supplies
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:CV
CIK
1378325
Web
N/A
Fax
N/A
Employees
90
Year Founded
N/A

Price Target and Rating

High Price Target
$6.00
Low Price Target
$5.00
Potential Upside/Downside
+34.1%
Consensus Rating
Strong Buy
Rating Score (0-4)
3.50
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
46,340,000
Free Float
N/A
Market Cap
$189.99 million
Optionable
N/A
Beta
N/A
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:CV) was last updated on 8/5/2025 by MarketBeat.com Staff
From Our Partners